Medtronic and Huashan Hospital Collaborate on Neuroscience in China
Medtronic Kanghui and Huashan Hospital of Fudan University signed a strategic cooperation agreement to build a “Neuroscience Industry-Medicine Integration Innovation Platform”, and at the same time inaugurated the Changzhou Technology Transformation Centre under the platform.
The collaboration will focus on patient needs, share technical achievements and resources, and create a “Neuroscience Industry-Medical Integration Innovation Platform” with a dumbbell dual-centre layout.
The Changzhou Technology Transformation Centre will be based on the four functions of Medtronic Kanghui Changzhou Science and Technology Park: Clinical Customer Centre, Intelligent Manufacturing Centre, R&D Centre of Excellence, and Innovation Incubation Centre, and will leverage world-class leading R&D and manufacturing technologies to complete the validation and incubation of innovative products, accelerate the process of commercialisation.
The two sides will make full use of their respective advantageous resources, focus on the clinical needs of cerebrovascular diseases, craniocerebral occupational diseases, functional nerves, craniocerebral trauma and critical neurological diseases, and establish a multi-channel resource linkage in precision navigation, artificial intelligence, brain-computer interfaces and other intelligent devices, new technologies and new materials, to jointly promote innovation, transformation and ecology, enhance efficiency and inject new vitality into the development of neuroscience in China.
As a research and development centre for neuroscience clinical diagnosis and treatment, Huashan Hospital focuses on demand-driven clinical research, academic exchanges for innovation and translation, and patent applications for research results. Professor Ying Mao, President of Huashan Hospital, said: “We are pleased to join hands with Medtronic to stay ahead of the curve, further embrace cutting-edge technology, enlighten clinical diagnosis and treatment thinking, cultivate high-level neuroscience and medical talents, and promote the development of China’s neuroscience industry into a new journey.
“Medtronic is committed to accelerating the development and landing of innovative products and supporting the incubation and commercialisation of innovative projects. Joining hands with Huashan Hospital to build a neuroscience industry-medicine integration innovation platform is another comprehensive strategic layout of Medtronic’s innovation value chain, and will also set an innovative benchmark for the “industry-university-research-medicine” synergy model. Ms. Jing Yu, Vice President of Medtronic and General Manager of Orthopaedics & Surgery Business Group of Medtronic China, said: “In the future, we will continue to strengthen local capacity building, optimise the industry-university-research-medicine co-innovation platform, promote the creation of a local innovation ecosystem, and join hands with the industry to provide more efficient, safer and personalised healthcare solutions for Chinese patients, contributing to the local innovation value chain of neuroscience in China and promoting the high-quality development of the discipline and industry! High-quality development of the discipline and industry!”
